KMPharmaceutical Co Ltd
KOSDAQ:225430
KMPharmaceutical Co Ltd
Total Equity
KMPharmaceutical Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KMPharmaceutical Co Ltd
KOSDAQ:225430
|
Total Equity
₩29.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Total Equity
₩5.3T
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Amorepacific Group
KRX:002790
|
Total Equity
₩3.4T
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Cosmax Inc
KRX:192820
|
Total Equity
₩457.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Total Equity
₩5.7T
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Total Equity
₩861.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
KMPharmaceutical Co Ltd
Glance View
KMPHARMACEUTICAL Co., Ltd. engages in the development and sale of oral health products. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2015-10-08. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The firm distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.
See Also
What is KMPharmaceutical Co Ltd's Total Equity?
Total Equity
29.8B
KRW
Based on the financial report for Sep 30, 2025, KMPharmaceutical Co Ltd's Total Equity amounts to 29.8B KRW.
What is KMPharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
3%
Over the last year, the Total Equity growth was -9%. The average annual Total Equity growth rates for KMPharmaceutical Co Ltd have been -10% over the past three years , 3% over the past five years .
